Reserpine administration by retrograde intravenous route in patients with Raynaud's phenomenon
Acevedo, A.; Arinoviche, R.; Palma, A.; Olea, E.; Guzmán, G.; Arriagada, M.; Grisanti, M.; Testar, R.
Revista Medica de Chile 110(11): 1063-1065
1982
ISSN/ISBN: 0034-9887 PMID: 7184095 Document Number: 186581
Document emailed within 1 workday
Related Documents
Zicot, M. 1980: Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine Revue Medicale de Liege 35(19): 652-654Cuenca, R.; Fernández-Cortijo, J.; Lima, J.; Fonollosa, V.; Simeón, C.P.; Pico, M.; Soriano, B.; Vilardell, M. 1990: Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma Medicina Clinica 95(20): 761-763
Dowd, P.M.; Martin, M.F.; Cooke, E.D.; Bowcock, S.A.; Jones, R.; Dieppe, P.A.; Kirby, J.D. 1982: Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2) British Journal of Dermatology 106(1): 81-89
Pratesi, F.; Corsi, C.; Deidda, C.; Nuti, A. 1976: Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon Schweizerische Rundschau für Medizin Praxis 65(44): 1368-1370
Kahan, A.; Weber, S.; Amor, B.; Guerin, F.; Degeorges, M. 1983: Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon New England Journal of Medicine 308(18): 1102-1103
Ritschel, W.A.; Kraus, C.; Shaaya, A.; Sakr, A. 1991: Pharmacokinetics of papaverine HCl upon intravenous route of administration in old and young beagle dogs Methods and Findings in Experimental and Clinical Pharmacology 13(1): 51-55
Arpaia, G.; Cimminiello, C.; Bellone, M.; Aloisio, M.; Rossi, F.; Bonfardeci, G. 1994: Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients International Angiology: a Journal of the International Union of Angiology 13(1): 15-18
Belch, J.J.; Land, D.; Park, R.H.; McKillop, J.H.; MacKenzie, J.F. 1988: Decreased oesophageal blood flow in patients with Raynaud's phenomenon British Journal of Rheumatology 27(6): 426-430
Kumagai, S.; Morinobu, A.; Ozaki, S.; Nakao, K.; Ishida, H. 1998: Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases Ryumachi 38(3): 504-510
Ohtsuka, T.; Yamakage, A.; Tamura, T. 1995: Image analysis of nail fold capillaries in patients with Raynaud's phenomenon Cutis 56(4): 215-218
Grossi, G.; Mariotti, A.; Di Donato, L.; Amerio, P.; Tulli, A.; Romani, G.L.; Merla, A. 2010: Functional infrared imaging of paroxysmal ischemic events in patients with Raynaud's phenomenon International Journal of Immunopathology and Pharmacology 23(2): 627-632
García-Carrasco, M.; Sisó, A.; Ramos-Casals, M.; Rosas, Jé.; de la Red, G.; Gil, V.; Lasterra, S.; Cervera, R.; Font, J.; Ingelmo, M. 2002: Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients Journal of Rheumatology 29(4): 726-730
Léger, P. 1998: Laser Doppler spectral analysis of patients with Raynaud's phenomenon during a standardized thermal test Annales de Dermatologie et de Venereologie 125(Suppl 2): S28-S29
Kuryliszyn-Moskal, A.; Kita, J.; Dakowicz, A.; Klimiuk, P.A. 2011: The usefulness of capillaroscopy for the evaluation of pulsed magnetic field therapy in patients with primary and secondary Raynaud's phenomenon Annales Academiae Medicae Stetinensis 57(3): 17-22; Discussion 22
Acevedo, A.; Schoop, W.; Schnell, A.; Toledo, L. 1990: Antibiotic treatment for diabetic foot. Advantages of intravenous regional route as alternative for systemic route Revista Medica de Chile 118(8): 881-888
Maricq, H.R.; Diat, F.; Weinrich, M.C.; Maricq, J.G. 1994: Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon Journal of Rheumatology 21(8): 1472-1476
Gustafson, J.H.; Benet, L.Z. 1974: Biliary excretion kinetics of phenolphthalein glucuronide after intravenous and retrograde biliary administration Journal of Pharmacy and Pharmacology 26(12): 937-944
Kawald, A.; Burmester, G.R.; Huscher, D.ör.; Sunderkötter, C.; Riemekasten, G. 2008: Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study Journal of Rheumatology 35(9): 1830-1837
Ratner, G.L.; Slutsker, G.E. 1991: Raynaud's phenomenon Khirurgiia 6: 36-40
Clément, D.L. 1980: Raynaud's phenomenon Revue Medicale de Liege 35(19): 633-634